Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Journal of Viral Hepatitis|May 30, 2008
Lower-than-standard dose peg-IFN alfa-2a for chronic hepatitis C caused by genotype 2 and 3 is sufficient when given in combination with weight-based ribavirinO Weiland, A Hollander, L Mattsson, et al.
American Journal of Physiology. Endocrinology and Metabolism|December 8, 2016
UCP1 inhibition in Cidea-overexpressing mice is physiologically counteracted by brown adipose tissue hyperrecruitmentAlexander W Fischer, Irina G Shabalina, Charlotte L Mattsson, et al.
Hepatology (Baltimore, Md.)|February 1, 1994
High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeksO Reichard, U Foberg, A Frydén, et al.
Gastroenterology|December 31, 1998
Limited humoral immunity in hepatitis C virus infectionM Chen, M Sällberg, A Sönnerborg, et al.
International Journal of Obesity (2005)|August 19, 2016
Mitochondria-targeted dodecyltriphenylphosphonium (C<sub>12</sub>TPP) combats high-fat-diet-induced obesity in miceA V Kalinovich, C L Mattsson, M R Youssef, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 26, 2018
Sensitization to minor cat allergen components is associated with type-2 biomarkers in young asthmaticsN Tsolakis, A Malinovschi, L Nordvall, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infectionO Weiland, M Chen, G Lindh, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infectionO Weiland, M Chen, G Lindh, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 19, 2009
The effect of plasma lipids on the pharmacokinetics of chlorpyrifos and the impact on interpretation of blood biomonitoring dataEzra R Lowe, Torka S Poet, David L Rick, et al.
Circulation|November 22, 2000
Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosisI Brochériou, D Stengel, L Mattsson-Hultén, et al.
Pageof 13